Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing - PubMed (original) (raw)

. 1995 Oct 15;55(20):4531-5.

Affiliations

PMID: 7553622

Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing

M Gonzalez-Zulueta et al. Cancer Res. 1995.

Abstract

Loss of heterozygosity on 9p21, where the p16/CDKN2 tumor suppressor and the p15INK4B cell cycle regulator genes are located, is a common genetic alteration in bladder cancer. However, it has been difficult to demonstrate homozygous deletions and intragenic mutations in either of these two genes in primary transitional cell carcinomas (TCC) of the bladder. Similarly, colon cancer-derived cell lines have shown no homozygous deletions of the p16/CDKN2 locus in contrast to a wide variety of tumor-derived cell lines. We have investigated abnormal methylation of the 5' CpG islands of the p16/CDKN2 and p15INK4B genes as an alternative mechanism of inactivation of these genes in bladder and colon cancers. De novo methylation of the 5' CpG island of p16/CDKN2 was observed in 12 of 18 (67%) uncultured bladder TCCs and in 2 of 3 (67%) bladder cell lines. In contrast, only 1 of 10 (10%) colon carcinomas showed methylation of the 5' CpG island of p16/CDKN2. It was striking to find that this region was extensively methylated and the gene not expressed in the normal colonic mucosa of 6 of 10 (60%) patients with colon cancer, whereas 5 of the corresponding colon tumors showed no methylation and high levels of p16/CDKN2 expression. Our data show a significant correlation (P = 0.00001, two-sided) between the absence of p16/CDKN2 expression and methylation of its 5' CpG island in bladder tumors, cell lines, and normal colon mucosa. In contrast, no association was observed between expression and methylation status of the 5' CpG island of p15INK4B. Our results suggest that the p16/CDKN2 tumor suppressor gene may be inactivated by methylation of its 5' CpG island in TCCs of the bladder. We also present evidence of methylation of the 5' CpG island in this autosomal gene in normal colonic tissue.

PubMed Disclaimer

Cited by

Hypomethylating agent-based therapies in older adults with acute myeloid leukemia - A joint review by the Young International Society of Geriatric Oncology and European Society for Blood and Marrow Transplantation Trainee Committee.
Neuendorff NR, Gagelmann N, Singhal S, Meckstroth S, Thibaud V, Zhao Y, Mir N, Shih YY, Amaro DMC, Roy M, Lombardo J, Gjærde LK, Loh KP. Neuendorff NR, et al. J Geriatr Oncol. 2023 Apr;14(3):101406. doi: 10.1016/j.jgo.2022.11.005. Epub 2022 Nov 23. J Geriatr Oncol. 2023. PMID: 36435726 Free PMC article. Review.
DNA methylation in promoter region as biomarkers in prostate cancer.
Yang M, Park JY. Yang M, et al. Methods Mol Biol. 2012;863:67-109. doi: 10.1007/978-1-61779-612-8_5. Methods Mol Biol. 2012. PMID: 22359288 Free PMC article.
DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers.
Iwase H, Omoto Y, Iwata H, Toyama T, Hara Y, Ando Y, Ito Y, Fujii Y, Kobayashi S. Iwase H, et al. Br J Cancer. 1999 Aug;80(12):1982-6. doi: 10.1038/sj.bjc.6690631. Br J Cancer. 1999. PMID: 10471050 Free PMC article.
Induction of the tumor-suppressor p16(INK4a) within regenerative epithelial crypts in ulcerative colitis.
Furth EE, Gustafson KS, Dai CY, Gibson SL, Menard-Katcher P, Chen T, Koh J, Enders GH. Furth EE, et al. Neoplasia. 2006 Jun;8(6):429-36. doi: 10.1593/neo.06169. Neoplasia. 2006. PMID: 16820088 Free PMC article.
Acromegaly: re-thinking the cancer risk.
Loeper S, Ezzat S. Loeper S, et al. Rev Endocr Metab Disord. 2008 Mar;9(1):41-58. doi: 10.1007/s11154-007-9063-z. Rev Endocr Metab Disord. 2008. PMID: 18157698 Review.

Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing - PubMed (original) (raw)